Neither dabigatran nor rivaroxaban was linked to increased GI bleeding compared with warfarin

被引：3
|
作者：
Koretz, Ronald L. [1 ]
机构：
[1] Olive View UCLA Med Ctr, Sylmar, CA 91342 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2015年 / 163卷 / 06期
关键词：
ORAL ANTICOAGULANTS; METAANALYSIS;
D O I：
10.7326/ACPJC-2015-163-6-013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study
    Ellis, Martin H.
    Neuman, Tsipora
    Bitterman, Haim
    Dotan, Sari Greenberg
    Hammerman, Ariel
    Battat, Erez
    Eikelboom, John W.
    Ginsberg, Jeffrey S.
    Hirsh, Jack
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 33 : 55 - 59
  • [32] Risk of Stroke and Major Bleeding for Dabigatran, Rivaroxaban, and Warfarin Compared to Apixaban Among Non-Valvular Atrial Fibrillation Patients in the United States Medicare Population
    Amin, Alpesh
    Keshishian, Allison
    Trocio, Jeffrey
    Dina, Oluwaseyi
    Le, Hannah
    Rosenblatt, Lisa
    Liu, Xianchen
    Mardekian, Jack
    Zhang, Qisu
    Baser, Onur
    Vo, Lien
    CIRCULATION, 2017, 136
  • [33] THE ANTITHROMBOTIC AND BLEEDING EFFECTS OF DABIGATRAN, A DIRECT THROMBIN INHIBITOR, AS COMPARED TO ENOXAPARIN, HEPARIN AND WARFARIN IN RATS
    Van Ryn, J.
    Kuritsch, I.
    Kink-Eiband, M.
    Priepke, H.
    Wienen, W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 407 - 407
  • [34] Management of gastrointestinal bleeding in patients anticoagulated with dabigatran compared with warfarin: a retrospective, comparative case review
    Manatsathit, Wuttiporn
    Al-hamid, Hussein
    Leelasinjaroen, Pornchai
    Hashmi, Usman
    McCullough, Peter A.
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2014, 4 (03) : 224 - 231
  • [35] Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation
    Aryal, Madan Raj
    Ukaigwe, Anene
    Pandit, Anil
    Karmacharya, Paras
    Pradhan, Rajesh
    Mainali, Naba Raj
    Pathak, Ranjan
    Jalota, Leena
    Bhandari, Yashoda
    Donato, Anthony
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (04): : 577 - 582
  • [36] Effectiveness and safety of apixaban, dabigatran and warfarin compared to rivaroxaban in non-valvular atrial fibrillation; a Norwegian nationwide cohort study
    Rutherford, O. -C. W.
    Jonasson, C. J.
    Ghanima, W. G.
    Halvorsen, S. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1846 - 1846
  • [37] Reduced Cerebral Bleeding Rates with Dabigatran Compared to Warfarin in Patients with Atrial Fibrillation: Results of RE-LY
    Diener, Hans-Christoph
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Pogue, Janice
    Wallentin, Lars
    Reilly, Paul A.
    Yusuf, Salim
    NEUROLOGY, 2010, 74 (09) : A281 - A281
  • [38] Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data
    Kohsaka, Shun
    Murata, Tatsunori
    Izumi, Naoko
    Katada, Jun
    Wang, Feng
    Terayama, Yasuo
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (11) : 1955 - 1963
  • [39] Experience in the Management of Upper Gastrointestinal Bleeding and Outcomes in Patients Taking Dabigatran Compared with Warfarin: A Retrospective, Comparative Study
    Manatsathit, Wuttiporn
    Al-Hamid, Hussein
    Gill, Baljinder
    Leelasinjaroen, Pornchai
    Hashmi, Usman
    Barawi, Mohamed
    McCullough, Peter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S464 - S465
  • [40] Efficacy and Safety of Prothrombin Complex Concentrate in Patients Treated with Rivaroxaban or Apixaban Compared to Warfarin Presenting with Major Bleeding
    Arachchillage, Deepa Jayakody
    Alavian, Sharon
    Griffin, Jessica
    Gurung, Kamala
    Syzdlo, Richard
    Karawitage, Nilanthi
    Laffan, Michael
    BLOOD, 2018, 132
12345